Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus: Table 1
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Dear Editor, We have reported that a vaccine based on the recombinant N-terminus of the candidal surface adhesin, Als3p (rAls3p-N), induced cross-kingdom protection against otherwise lethal intravenous infection caused by the bacterium, Staphylococcus aureus (Spellberg et al., 2008). Vaccine efficacy was mediated by CD3 lymphocytes, predominantly with a T helper type 1 (Th1) phenotype; humoral immunity was neither necessary nor sufficient to mediate protection. Nevertheless, because Th1 cells do provide help to B cells and stimulate production of antibody, and antibody titers are elevated even during polarized type 1 immune responses (Mosmann et al., 1986; Smith et al., 2000), we hypothesized that antibody titers could serve as surrogate markers of protection for the rAls3p-N vaccine, despite the fact that the vaccine mediates protection by inducing cell-mediated immunity. To determine the potential for antibody titers to serve as accurate surrogate markers of protection for our anti-S. aureus vaccine, we studied serum banked from 32 mice vaccinated and infected in the previously published study (Spellberg et al., 2008). Antibody titers were determined by enzyme-linked immunosorbent assay, as previously described (Spellberg et al., 2005,; 2006), and compared with the known time to death from infection. A single dose of vaccine plus 0.1% aluminum hydroxide adjuvant [Al(OH)3] resulted in a >20-fold increase in median titers of both total immunoglobulin G (IgG) and IgG2a antibodies compared with Al(OH)3 alone (IgG titers=1 : 4800 vs. 1 : 200; IgG2a titers=1 : 1600 vs. 1 : 50, P<0.01 for both comparisons). Two doses of vaccine resulted in an additional 10-fold rise in median titers of IgG antibodies [IgG titers=1 : 51 200 vs. 1 : 200; P<0.01 vs. both Al(OH)3 alone and one dose of vaccine]. Surviving vaccinated and adjuvant control mice had higher anti-rAls3p-N IgG (12 800 vs. 200; P=0.03) and IgG2a (3200 vs. 200; P=0.002) titers than those that died from infection. However, IgG titers were similar between vaccinated mice (exclusive of adjuvant control mice) that did or did not survive subsequent infection (25 600 vs. 25 600; P=0.9). Furthermore, there was no correlation between individual IgG antibody titers and time to death when comparing all mice (ρ=0.2, P=0.1), all vaccinated mice [including both one and two doses of rAls3p-N plus Al(OH)3] (ρ=0.01, P=0.7), or in mice vaccinated with one dose (ρ=0.2, P=0.4) or with two doses (ρ=−0.2, P=0.99). In contrast, in vaccinated mice (exclusive of adjuvant control mice) anti-rAls3p-N IgG2a titers were higher in survivors than nonsurvivors (4800 vs. 800; P=0.01). Furthermore, IgG2a titers correlated with time to death (ρ=0.4, P=0.02), even when excluding adjuvant control mice and analyzing only mice vaccinated with either one or two doses (ρ=0.7, P=0.003), or mice vaccinated with one dose (ρ=0.7, P=0.049), or with two doses (ρ=0.8, P=0.02) of rAls3p-N plus Al(OH)3. Similarly, the ratio of IgG2a/IgG antibody titers in individual mice vaccinated with rAls3p-N plus Al(OH)3 was higher in survivors than nonsurvivors (median ratio=0.5 vs. 0.03; P=0.049). IgG2a/IgG ratios correlated with time to death when analyzing just mice vaccinated with either one or two doses (ρ=0.5, P=0.02), or in mice vaccinated with one dose (ρ=0.8, P=0.03), or with two doses (ρ=0.8, P=0.02) of rAls3p-N plus Al(OH)3. No IgG titer had a positive or negative predictive value, or overall accuracy, of >70%, at predicting survival in vaccinated mice (exclusive of adjuvant control mice) (Table 1). In contrast, an IgG2a titer of ≥3200 had 86% positive and negative predictive values, and an overall accuracy of 86% for survival. An IgG2a titer of ≥1 : 6400 had 100% positive predictive value for survival, but the negative predictive value fell to 64%, resulting in an overall accuracy of 73%. Accuracy of antibody titer cut-offs for predicting survival in mice vaccinated with one or two doses of rAls3p-N+Al(OH)3 and infected with Staphylococcus aureus No vaccinated mice had titers <1600; hence, the NPV=0/0. Sensitivity, number of surviving mice with titers greater than or equal to the cut-off/number of all surviving mice; specificity, number of mice that died with titers less than the cut-off/number of all mice that died; PPV, positive predictive value, which is the percentage of mice with titers greater than or equal to the cut-off that survived; NPV, negative predictive value, which is the percentage of mice with titers less than cut-off that died; accuracy=[(number of mice with titers greater than or equal to the cut-off that survived infection)+(number of mice with titers less than the cut-off that died from infection)/(all mice)]. NA, not applicable. Accuracy of antibody titer cut-offs for predicting survival in mice vaccinated with one or two doses of rAls3p-N+Al(OH)3 and infected with Staphylococcus aureus No vaccinated mice had titers <1600; hence, the NPV=0/0. Sensitivity, number of surviving mice with
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542 · cited 3×
“Furthermore, a recent study reported that a major mechanism by which aluminum adjuvants enhance immune responses was by direct agonism of an intracellular pattern recognition receptor, Nalp3 (Eisenbarth et al ., 2008).”
BackgroundInfluentialRegulation of antibody isotype secretion by subsets of antigen-specific helper T cells
Stevens, T. L., Bossie, A., Sanders, V. M., Fernandez-Botran, R., Coffman, R. L., Mosmann, T. R., & Vitetta, E. S. (1988) · Nature · doi:10.1038/334255a0 · Cited by 933 · cited 11×
“IgG2a/IgG ratios correlated with time to death when analyzing just mice vaccinated with either one or two doses (r= 0.5, P = 0.02), or in mice vaccinated with one dose (r= 0.8, P = 0.03), or with two doses (r= 0.8, P = 0.02) of rAls3p-N plus Al(OH)3.”
InfluentialVaccines: Correlates of Vaccine‐Induced Immunity
Plotkin, S. A. (2008) · Clinical Infectious Diseases · doi:10.1086/589862 · Cited by 829
Spellberg, B. J., Ibrahim, A. S., Avanesian, V., Fu, Y., Myers, C., Phan, Q. T., Filler, S. G., Yeaman, M. R., & Edwards, Jr. (2006) · The Journal of Infectious Diseases · doi:10.1086/504691 · Cited by 180
Self-citation
Cited by
Progress Toward a Staphylococcus aureus Vaccine
Daum, R. S., & Spellberg, B. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cir828 · Cited by 165
Self-citationThe NDV-3A vaccine protects mice from multidrug resistant Candida auris infection
Singh, S., Uppuluri, P., Mamouei, Z., Alqarihi, A., Elhassan, H., French, S., Lockhart, S. R., Chiller, T., Edwards, J. E., & Ibrahim, A. S. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1007460 · Cited by 162
Self-citationUppuluri, P., Lin, L., Alqarihi, A., Luo, G., Youssef, E. G., Alkhazraji, S., Yount, N. Y., Ibrahim, B. A., Bolaris, M. A., Edwards, J. E., et al. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007056 · Cited by 57
Self-citationNaglik, J. R. (2014) · New Journal of Science · doi:10.1155/2014/390241 · Cited by 29
Metadata
- Authors
- Lin, L., Ibrahim, A. S., Baquir, B., Avanesian, V., Fu, Y., & Spellberg, B.
- Venue
- FEMS Immunology & Medical Microbiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04
- Volume
- 55
- Issue
- 3
- Pages
- 293-295
- ISSN
- 0928-8244 (ISSN-L)
- 1574-695X
- OpenAlex
- W2042686220
- Cited by
- 29
- References
- 4
- FWCI
- 2.51
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus: Table 1. https://app.cochat.ai/papers/10.1111/j.1574-695x.2008.00531.x
- The paper
- Lin, L., Ibrahim, A. S., Baquir, B., Avanesian, V., Fu, Y., & Spellberg, B. (2009). Immunological surrogate marker of rAls3p-N vaccine-induced protection against Staphylococcus aureus: Table 1. FEMS Immunology & Medical Microbiology. https://doi.org/10.1111/j.1574-695x.2008.00531.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.